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Peptidoglycan-polysaccharide (PG-PS) fragments were purified from cell walls of group D streptococci
(Streptococcus faecium, strains ATCC 9790 and F-24) with a protocol which minimizes autolytic activity and
tested for ability to induce arthritis in rats. PG-PS fragments from cell walls of other normal flora bacteria
(Peptostreptococcus productus, and Propionibacterium acnes), group A streptococci, and pseudomurein-PS
fragments from cell walls of Methanobacterium formicicum, were similarly purified and tested. Upon
intraarticular injection into rat ankles, all PG-PS polymers induced acute inflammation; pseudomurein-PS
fragments were approximately five times less active than the PG-PS preparations. After intraperitoneal
injection, P. acnes PG-PS induced a minimal acute arthritis, Peptostreptococcus productus PG-PS induced a
moderately severe acute joint inflammation followed by a mild chronic arthritis, and both group A and group
D streptococcal PG-PS induced severe acute arthritis which evolved into chronic, erosive joint disease;
pseudomurein-PS fragments were without effect, consistent with a crucial role for the PG moiety of PG-PS.
Chronic arthritis induced by group D streptococcal PG-PS subsided after 60 days, whereas that induced by
group A streptococcal PG-PS was still active after 128 days. The arthropathic properties of this modest number
of common normal flora bacteria suggest that different PG-PS structures derived from the normal flora have
the potential to induce a wide range of responses, from transient acute to chronic erosive joint disease.
A single intraperitoneal (i.p.) injection of a sterile, aque-
ous suspension of peptidoglycan-polysaccharide (PG-PS)
fragments purified from group A streptococcal cell walls
induces a chronic, erosive, recurrent polyarthritis in rats
which resembles human rheumatoid arthritis in clinical,
histologic, and radiologic detail (13). Based on the chronic
arthropathic activity of sonically treated material of several
other gram-positive bacteria (13) and the ubiquitous natural
distribution of PG-containing polymers, Schwab (36) and
Cromartie (12) hypothesized that cell wall polymers from
many bacteria, including normal flora species, might possess
arthropathic activity, and further postulated that increased
exposure to these polymers during intestinal injury might be
relevant to the association of chronic arthritis with ulcerative
colitis, Crohn's disease, Whipple's disease, and intestinal
bypass surgery for obesity (2). These ideas are supported by
recent reports of chronic erosive arthritis induced in rats by
cell wall polymers from group B streptococci (43) and
Lactobacillus casei (29).
The present study was undertaken to extend our knowl-
edge of the arthropathic properties of cell wall polymers
from normal flora bacteria and to take advantage of the
natural structural diversity of these polymers in the evalua-
tion of structure-function relationships. Previous studies of
the group A streptococcal PG-PS indicated that the relative
severity of acute and chronic phases of arthritis was deter-
mined by PG-PS fragment size, which could be altered by
physical (i.e., sonication) or enzymatic (i.e., muralytic di-
gestion) means (8, 20). Therefore, cell wall polymers were
purified by a protocol which minimizes autolytic activity. In
addition, fragments were prepared which were similar in size
to those of group A streptococcal PG-PS which induce the
most severe chronic erosive joint disease (20). Our aim was
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to prepare cell wall fragments which, on the basis of past
I studies of the group A streptococcal PG-PS, would be most
likely to induce chronic arthritis. PG-PS polymers were
purified from two strains of Streptococcus faecium (group
D), which is commonly isolated from human feces (44), and
the anaerobes Peptostreptococcus productus, one of the 10
bacterial species most commonly isolated from human feces
(23), and Propionibacterium acnes, a common isolate from
human skin (30) and feces (23). The chemical compositions,
in vitro lysozyme sensitivities, and arthropathic activities of
these various cell wall polymers are described in this report.
MATERIALS AND METHODS
Bacterial strains. The following bacterial strains were used:
Streptococcus pyogenes (group A, type 3) strain D-58, S.
faecium (group D) strain F-24, S. faecium (group D) strain
ATCC 9790 (obtained from G. D. Shockman, Temple
University School of Medicine, Philadelphia, Pa.), Pepto-
streptococcus productus VPI C18-23 (obtained from the
Anaerobe Laboratory, Virginia Polytechnic Institute and
State University, Blacksburg, Va.), Propionibacterium acnes
VPI 0009 (obtained from C. S. Cummins, Virginia Polytech-
nic Institute and State University).
In addition, Methanobacterium formicicum JF-1 was ob-
tained as a frozen pellet of partially disintegrated whole cells
from J. G. Ferry, Virginia Polytechnic Institute and State
University. These bacteria were grown under strict anaero-
bic conditions with formate as the sole energy source, as
previously described (34). After harvest by continuous-flow
centrifugation, whole cells were disrupted by passage
through a French pressure cell. The eluate was centrifuged
at 10,000 x g for 20 min, and the pellet was frozen to -70°C,
sent to us on dry ice, and maintained at -70°C until use in
cell wall purification.
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FIG. 1. Inactivation of the autolytic activity of S. faecium group
D ATCC 9790 whole cells by heating at 80°C for 30 min. Heated and
nonheated control cells were suspended in PBS at 37°C, and lysis
was measured at A560.
Cell wall purification. All bacterial strains, except M.
formicicum, were grown to early-stationary phase in a
15-liter fermenter (The VirTis Co., Gardiner, N.Y.) at 37°C.
During growth, additional glucose was added (1 liter of 45%
glucose at 3 ml/min), and the pH was automatically main-
tained at 7.0 (6.5 for Peptostreptococcus productus) by the
addition of 10% NaOH, essentially as described by Fox et al.
(20). Streptococci were grown aerobically in Todd-Hewitt
broth (BBL Microbiological Systems, Cockeysville, Md.)
supplemented with Tween 80 (0.02%). P. acnes was grown
anaerobically in Todd-Hewitt broth supplemented with the
reducing agents sodium formaldehyde sulfoxylate (Eastman
Kodak Co., Rochester, N.Y.) and cysteine (both at 0.03%)
and Tween 80 (0.02%). Peptostreptococcus productus was
grown anaerobically in brain heart infusion broth (BBL
Microbiological Systems) supplemented with yeast extract
(0.9%; Difco Laboratories, Detroit, Mich.), in addition to the
concentrations of reducing agents and Tween 80 indicated
above. All bacteria were harvested and cell walls were
prepared in a similar manner as follows. To reduce autolytic
and other metabolic activity, the culture was rapidly cooled
to 4°C by passing -70°C ethanol through the heat exchange
pipes of the fermenter. Bacteria were then harvested by
continuous-flow centrifugation at 4°C. The pellet was sus-
pended in cold phosphate-buffered saline (PBS), rapidly
heated to 80°C by swirling in a boiling water bath, and
maintained at 80°C for 30 min to inactivate autolytic en-
zymes (6, 40, Fig. 1). Bacteria were then washed three timnes
with PBS, resuspended in PBS, and broken by shaking with
glass beads in a Braun MSK cell homogenizer (Bronwill
Scientific Inc., Rochester, N.Y.) cooled with liquid carbon
dioxide. The partially disintegrated cells of M. formicicum
were also briefly shaken with glass beads for more complete
disruption. Cell walls (including those from M. formicicum)
were separated from glass beads by filtration through a
coarse-sintered glass filter, and the filtrate was centrifuged at
30,000 x g for 30 min. The resulting pellet consisted of a
small hard-packed residuum of whole cells covered by a
much larger, less dense layer of crude cell walls. The cell
wall portion was suspended in approximately four times its
packed volume in 2% sodium dodecyl sulfate (Sigma Chem-
ical Co., St. Louis, Mo.) and extracted for 2 h at 56°C. This
extraction was repeated twice. Hot sodium dodecyl sulfate
extractions were used to inactivate any residual autolytic
activity and to remove contaminating lipid, protein, and
nucleic acid (40). After each centrifugation, any remaining
small pellet of whole cells was discarded. Cell walls were
washed extensively (at least 10 times) with PBS at room
temperature. After approximately the fourth wash, superna-
tants contained less than 0.003% sodium dodecyl sulfate as
judged by the lack of a precipitate with 4 M KCl. Walls were
then washed three times with distilled water, dialyzed
against several changes of distilled water for at least 5 days,
and lyophilized. This entire procedure was carried out under
aseptic conditions, and the purified cell wall preparations
wete sterile as judged by the lack of growth on blood agar
plates.
Cell wall composition. Neutral sugars and amino sugars
were liberated by hydrolysis of purified cell walls in vacuo
for 2 h in 2 N sulfuric acid at 100°C, converted to their alditol
acetates, and analyzed by gas-liquid chromatography with
xylose and methylglucamine (Sigma Chemical Co., St.
Louis, Mo.) as internal standards, as previously described
(21). Rhamnose was also determined colorimetrically by the
method of Dische and Shettles (18). Prior to hydrolysis, cell
walls from P. acnes and Peptostreptococcus productus were
N acetylated by the method of Heymann et al. (22). This
greatly increased the yield of muramic acid and glucosamine
from these walls (25).
Amino acids were liberated by hydrolysis of purified cell
walls for 18 h in vacuo in 6 N HCl at 110°C and quantitated
on a high-pressure liquid chromatography-amino acid ana-
lyzer (Waters Associates, Inc., Milford, Mass.) (10).
Preparation and fractionation of cell wall fragments. Puri-
fied cell walls from each bacterial strain were sonicated and
fractionated in an identical manner. Lyophilized cell walls
were suspended in PBS at a concentration of 20 mg/ml,
placed in a 20-ml stainless steel cup, and sonicated with
cooling for 35 min, followed by a 15-min cooling period and
another 35-min sonication, in a Branson model 350 Sonifer
(Branson Sonic Power Co., Danbury, Conn.). Recently, we
have found that a single 35-min sonication is sufficient to
generate a wide range of fragment sizes from cell walls
prepared by the sodium dodecyl sulfate extraction method.
Therefore, in the experiment depicted in Fig. 5, rats were
injected with fragments derived from a 35-min instead of
70-min sonication of cell walls. The sonically treated mate-
rials were centrifuged at 10,000 x g for 30 min to yield pellet
and supernatant fractions. The supernatant fraction (10,000
x g) was further centrifuged at 100,000 x g for 60 min to
yield pellet (100P) and supernatant fractions. The average
molecular weight of the predominant group A streptococcal
cell wall fragments in these fractions has been determined to
be 500 x 106(10,000 x g pellet), 50 x 106 (100P), and 5 x 106
(100,000 x g supernatant) (20).
Experimental animals and induction of arthritis. Outbred
female Sprague-Dawley rats 6 to 8 weeks old were obtained
from Zivic-Miller Laboratories, Allison Park, Pa. Eight to
ten rats were used per group. Arthritis was induced by
injection of sterile suspensions of cell wall fragments in PBS
by either the intra-articular (i.a.) or i.p. route. Immediately
prior to injection, each suspension was sonicated for 3 min to
evenly disperse the fragments. The dose and fraction of
fragments used are indicated in the Results. For i.a. injec-
tion, 10 ,ul of a suspension was injected into the right ankle
of each rat through the Achilles tendon just above the
calcaneus with a 25-gauge needle adapted to a micropipette
(R. E. Esser, S. A. Stimpson, W. J. Cromartie, and J. H.
Schwab, Arthr. Rheum., in press). Left ankle joints received
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TABLE 1. Cell wall composition: sugars and amino sugars
,umol of sugar or amino sugar/mg (% [dry wt])
Organism
Rhamnose Mannose Galactose Glucose Muramic Glucos- Galactos-acid amine amine
Streptococcus pyogenes 1.9 (31.5) Oa (0) 0 (0) 0 (0) 0.17 (4.3) 1.2 (21.0) 0 (0)
(group A, type 3)
Streptococcus faecium ATCC 1.1 (18.6) 0 (0) 0 (0) 1.0 (18.7) 0.44 (11.0) 0.47 (8.4) 0.20 (3.6)
9790
Streptococcus faecium F-24 1.1 (18.1) 0 (0) 0.46 (8.2) 0.75 (13.5) 0.31 (7.9) 0.26 (4.6) 0.20 (3.6)
Peptostreptococcus productus 1.7 (27.5) 0 (0) 0.34 (6.2) 0.28 (5.0) 0.22 (5.6) 0.29 (5.2) 0.59 (10.6)
VPI C18-23
Propionibacterium acnes VPI 0 (0) 0.17 (3.0) 0.29 (5.3) 0.33 (6.0) 0.31 (7.7) 0.39 (7.0) 0.05 (0.9)
ooosb
Methanobacterium formicicum 1.6 (25.8) 0.18 (3.2) 0.39 (7.0) 0 (0) 0 (0) 0.68 (12.2) 0.5 (9.0)
JF-1
a A value of zero indicates that the component was not detected by our methods. No ribose, deoxyribose, or fucose was found in any of the cell wall
preparations.
b P. acnes cell wall PS also contains 3 to 5% 2,3-diamino-2,3-dideoxyglucuronic acid (16).
10 RI1 of sterile PBS alone. For i.p. injection, 0.5 ml of
suspension was injected per rat, and control groups received
0.5 ml of sterile PBS alone.
The severity of inflammation in each extremity was scored
grossly on a scale of 0 (no apparent inflammation) to 4
(severe inflammation) based on erythema and edema of the
periarticular tissues and enlargement of the joints, as previ-
ously described (13). The maximum score possible after an
i.a. injection was 4 (inflammation was noted only in the ankle
injected with cell wall polymers), and it was 16 after an i.p.
injection (inflammation was assessed in the joints of each
extremity distal to the knees and elbows).
After the i.p. injection of group A streptococcal cell wall
fragments, it was our experience that an occasional rat never
develops gross evidence ofjoint inflammation. However, the
responses of all rats are included in the statistical calcula-
tions, even though some of these negative responses are
probably due to inadvertent injection into the intestine.
Histology. In the first experiment, groups of rats were
injected with group A or group D (ATCC 9790 or F-24)
streptococcal cell wall fragments (all at 130 ,ug [dry weight]/g
of body weight) or PBS alone. On days 3, 30, and 60 after
injection, three rats from each group were sacrificed. In the
second experiment, which focused on a comparison of the
chronic phase of disease (see Fig. 5), all rats were sacrificed
on day 128. Immediately after sacrifice, skinned ankle joints
were removed, fixed in 10% Formalin, and decalcified in
EDTA. Paraffin sections were then prepared and stained
with Weigart hematoxylin and alcoholic eosin (13).
Radiology. Rats were anesthetized with an intramuscular
injection of Innovar (droperidol-fentanyl citrate; McNeil
Laboratories, Inc., Ft. Washington, Pa.), and ankles were
radiographed on Kodak projector slide plates (100 to 200 line
pairs per mm) with a microradiographic unit (Faxitron model
43804; Hewlett-Packard Co., McMinnville, Oreg.). The ra-
diographs were evaluated for evidence of the presence and
severity of soft tissue swelling, demineralization, erosions,
subperiosteal new bone, joint space narrowing, degenerative
changes, and alignment alterations by a grading system
previously described (9).
RESULTS
Cell wall composition. The sugar, amino sugar, and amino
acid composition of cell walls from the various bacterial
strains used in this study are shown in Tables 1 and 2. The
res,ults indicate that all are complexes of PG, or pseudomu-
rein in the case of M. formicicum, and PS. These analyses
are consistent with current knowledge of the structure of cell
walls from these bacteria. Four different PG structures are
represented here. All contain L-alanine and D-glutamic acid
in the first two positions of the peptide but differ in the type
of diamino acid and the nature of the cross-linkage
(interpeptide bridge). Group A streptococcal PG contains
lysine and is cross-linked with a dipeptide of L-alanine (35).
S. faecium (group D) PG contains lysine and is cross-linked
with a single residue of D-isoasparagine (27). Peptostrepto-
coccus productus PG contains meso-diamninopimelic acid
and is directly cross-linked (46). P. acnes VPI 0009 PG
contains L,L-diaminopimelic acid (14), and although glycine
is present as either an N- or C-terminal residue on L,L-
TABLE 2. Cell wall composition: amino acids
Molar ratioa of amino acid (% [dry wt])
Organism Aspartic Glutamic Diamino-
acid acid Glycine Alanine Lysine pimelic
acid
Streptococcus pyogenes (group A, type 3) 0 (_)b 1.1 (7.5) 0 (-) 2.9 (11.5) 1.0 (6.6) 0 (-)
Streptococcus faecium ATCC 9790 1.1 (5.1) 1.3 (6.5) 0 (-) 2.0 (6.1) 1.0 (5.1) 0 (-)
Streptococcus faecium F-24 0.9 (3.7) 1.1 (5.2) 0 (-) 1.7 (4.8) 1.0 (4.7) 0 (-)
Peptostreptococcus productus VPI C18-23 0 (-) 0.9 (5.5) 0 (-) 2.2 (8.2) 0 (-) 1.0 (8.0)
Propionibacterium acnes VPI 0009 0 (-) 0.8 (8.2) 0.8 (4.1) 1.7 (10.7) 0 (-) 1.0 (13.3)
Methanobacteriumformicicum JF-1 0 (-) 2 (12.5) 0 (-) 1.3 (4.9) 1.0 (6.3) 0 (-)
a For the molar ratio, lysine or diaminopimelic acid was 1.0.
b -, Amino acid was either not found or detected only in trace amounts (less than 0.06 p.mol/mg).
INFECT. IMMUN.










FIG. 2. Lysis of various PG-PS polymers by hen egg white lysozyme. Purified, unsonicated PG-PS polymers from various bacteria were
suspended at approximately 1 mg/ml in 25 mM sodium phosphate buffer with 0.2% NaCi (pH 7.0) diluted at time zero with an equal volume






















pL I I I In ~
I0h 2 4 6 8 10 12 14
TIM E (days)
16 18 20 22 24
FIG. 3. Inflammation induced in rat ankle joints by the i.a.
injection of PG-PS lOOP fragments isolated from group A and group
D streptococci, Peptostreptococcus productus, and P. acnes and
pseudomurein-PS fragments from M. formicicum. The dose indi-
cated was injected into the right ankle of each rat. Left ankles
received PBS alone and did not become inflamed (data not shown).
Joint inflammation induced by group A streptococcal PG-PS was
significantly more severe than that induced by group D streptococ-
cal PG-PS on the days indicated by asterisks (12 rats per group,
diaminopimelic acid, recent reports indicate that this PG is
directly cross-linked (24, 25). M. formicicum cell walls
contain pseudomurein instead of the conventional PG struc-
ture, which has L-N-acetyltalosaminuronic acid instead of
D-N-acetylmuramic acid, and also contains no D-amino acids
(26, 28). Although N-acetyltalosamintronic acid was not
measured here, we found no trace of muramic acid, and the
molar ratios of the amino acids are consistent with that
previously reported (26).
Only the PS from group A streptococci has been studied in
detail, and otir compositional analyses are consistent with
the current knowledge of this structure (11). The grouping
polysaccharide of group D streptococci is a membrane
component (39), and antigenic differences in the cell wall
(type specific) PS are known to exist among different strains
in this group (6). The only major difference we found in the
composition of cell walls from the F-24 and ATCC 9790
strains of S. faecium was the presence of galactose in F-24.
Recent studies on the penicillin-induced secretion of high-
molecular-weight cell wall polymers from autolytic-defective
mutants of ATCC 9790 suggest that S. faecium PG could be
substituted with at least two different types of PS structures
(R. Kariyama, D. L. Dolinger, and G. D. Shockman, Abstr.
Annu. Meet. Am. Soc. Microbiol. 1985, K85, p. 185).
The purified cell wall polymers used in this study are
referred to as PG-PS or pseudomurein-PS polymers to
distinguish them from crude or native cell walls which
contain proteins, nucleic acids, and other cellular compo-
nents.
Lysozyme sensitivity of purified cell wall polymers. The
P < 0.001). Symbols: 0, 10 Fg of S. pyogenes (group A) PG-PS; 0,
10 ,ug of S. faecium (group D) ATCC 9790 PG-PS; A, 10 ,ug of P.
acnes PG-PS; A, 10 ,ug of Peptostreptococcus productus PG-PS; *,
10 pug of M. formicicum pseudomurein-PS; El, 50 ,ug of M.
formicicum pseudomurein-PS.
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FIG. 4. Arthritis induced by i.p. injection of various P?G-PS lOOP fragments into rats. Dosages: S. pyogenes (group A), 130 ,zg [dry
weight]/g of body weight; S.faecium (group D) ATCC 9790, 200 ,ug [dry weight]/g of body weight; Peptostreptococcus productus, 200 F.g [dry
weight]/g of body weight; and P. acnes, 200 ,ug [dry weight]/g of body weight. A negative control group which received PBS alone never
developed arthritis. For clarity, standard errors are not indicated for every data point. Symbols: 0, S. pyogenes; 0, S. faecium ATCC 9790;
i\, Peptostreptococcus productus; *, P. acnes.
sensitivity of the various PG-PS polymers to hen egg white
lysozyme is shown in Fig. 2. We confirm the findings that
PG-PS polymers from P. acnes (15) and S. pyogenes (37) are
not sensitive, while those from S. faecium ATCC 9790 (1, 41)
are sensitive to lysozyme. Peptostreptococcus productus
PG-PS had an intermediate sensitivity to lysozyme. Other
studies indicated that the lysozyme sensitivities of PG-PS
from group D streptococcal strains ATCC 9790 and F-24 did
not differ, that pseudomurein-PS polymers from M.
formicicum were not lysed by lysozyme and that all purified
cell wall polymer preparations were stable as judged by the
lack of detectable lysis in PBS alone (data not shown).
Joint inflammation induced by i.a. injection of cell wall
polymers. Figure 3 shows the course of arthritis induced by
a single i.a. injection of the 100P fragments of the various cell
wall polymers. All induced an acute inflammation which
peaked by 12 to 24 h and gradually subsided. S. pyogenes
(group A) PG-PS induced the most severe, prolonged inflam-
mation, which was significantly more severe than that in-
duced by the same dose of S. faecium (group D) PG-PS from
day 4 to the termination of the experiment. Of the PG-PS
fragments tested, that from P. acnes induced the least severe
inflammation. Pseudomurein-PS fragments from M. formici-
cum were less active than any of the PG-PS preparations.
Approximately five times more pseudomurein-PS was re-
quired to induce an acute inflammation equal in severity to
that induced by PG-PS fragments.
Arthritis induced by i.p. injection of cell wall polymers.
Figure 4 depicts the course of arthritis induced by a single
i.p. injection of the 100P fragments of various cell wall
polymers. Group A streptococcal PG-PS, as described in
detail previously (13), induced an acute arthritis peaking at
day 3, followed by a partial resolution and then recurrence of
inflammation by 3 weeks after injection. Repeated episodes
of remission and exacerbation of arthritis continued through-
out the chronic phase of disease, and severe arthritis was
still grossly evident when the experiment was terminated on
day 75. Group D streptococcal ATCC 9790 PG-PS induced a
severe acute arthritis peaking about 1 week after injection
which did not begin to decrease in severity until 5 weeks
later. At the termination of the experiment, arthritis ap-
peared to be resolving, in contrast to the ongoing joint
disease seen in group A streptococcal PG-PS-injected rats.
This observation prompted the detailed comparison of group
A and group D streptococcal PG-PS-induced arthritis in the
long-term experiment described below. Peptostreptococcus
productus PG-PS induced a moderately severe acute arthri-
tis which peaked at day 3, followed by a mild chronic disease
in two of the eight rats injected. P. acnes PG-PS induced
very little acute and no chronic arthritis upon i.p. injection.
No arthritis was seen in negative control rats injected with
PBS alone.
In other experiments (data not shown), the i.p. injection of
M. formicicum pseudomurein-PS 100P fragments (250 ,ug
[dry weight]/g of body weight, 4 rats, 30-day observation
period) or 10,000 x g-supernatant fragments (250 pLg [dry
weight]/g of body weight, 8 rats, 42-day observation period)
did not induce any gross evidence of joint inflammation or
other toxic effects, such as the transient inactivity of the
animals which often follows the i.p. injection of a similar
dose of PG-PS fragments.
Comparison of arthritis induced by i.p. injection of PG-PS
fragments from group A and group D streptococci. The gross,
histologic, radiologic, and recurrent features of arthritis
induced by PG-PS 100P fragments isolated from group A and
two strains of group D streptococci were compared. Figure
5 shows the course of arthritis as judged by gross inspection
of the joints. All three preparations induced an acute arthritis
which peaked about day 4. Group A streptococcal PG-PS
induced a typical response, with partial resolution of the
acute reaction, followed by a recurrence of inflammation 3
weeks later, which evolved into a chronic irreversible joint
disease. The meaft severity of this chronic phase remained at
a high level for the duration of the experiment, and the phase
was characterized by repeated episodes of remission and
exacerbation in individual joints (Table 3). Ankylosis of
many joints became grossly apparent after approximately 2
months. Acute arthritis induced by the two group D strep-
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FIG. 5. Arthritis induced in rats by the i.p. injection of PG-PS fragments (150 ,ug [dry weight]/g of body weight) isolated from S. pyogenes
(group A) (0), S. faecium (group D) ATCC 9790 (0), and S. faecium (group D) F-24 (A). Ten rats were injected in each test group. A negative
control group which received PBS alone never developed arthritis (data not shown). The level of significance between the three groups was
calculated for each day that scores were recorded. For clarity, standard errors are not indicated for every data point. Arthritis was more
severe in group A than group D (either strain) PG-PS-injected rats on days 40 to 61 (P < 0.05) and 68 to 128 (P < 0.001). Other statistical
comparisons are indicated in the text.
tococcal preparations also evolved into a chronic phase, but
in contrast to that induced by group A streptococcal PG-PS,
significantly fewer episodes of recurrent inflammation were
observed (Table 3), and grossly apparent inflammation began
to resolve after about 35 days. After day 80, joints no longer
had the erythematous, warm, inflamed appearance of joints
from group A streptococcal PG-PS-injected rats, and little
ankylosis was noted.
The patterns of arthritis induced by PG-PS fragments from
the two group D streptococcal strains were not identical
(Fig. 5). The ATCC 9790 PG-PS induced an acute and early
TABLE 3. Comparison of the recurrent and radiologic features of
arthritis induced by i.p. injection of S. pyogenes or S. faecium
PG-PS fragmentsa
Mean no. of Mean radiologic score +PG-PS source exacerbations/rat + SEMSEMbSE
S. pyogenes (group 6.7 + 1.2 5.6 ± 1.3
A)
S. faecium (group 2.8 ± 0.8 (P < 0.01) 1.7 ± 0.3 (P < 0.005)
D) ATCC 9790
S. faecium (group 2.2 ± 0.8 (P < 0.005) 1.3 ± 0.5 (P < 0.005)
D) F-24
a Data in this table are based on the experiment depicted in Fig. 5.
Significant difference is given for S. pyogenes PG-PS-injected versus S.
faecium PG-PS-injected rats.
b The course of arthritis in each ankle and wrist joint of each rat was
examined for spontaneous exacerbations of grossly apparent inflammation. A
successive decrease and increase of at least 1 joint score unit was considered
an exacerbation. The number of exacerbations observed in each of the four
joints was summed and expressed as the number of exacerbations per rat.
'On day 110 after PG-PS injection, the ankle joints were analyzed for
radiologic evidence of arthritis. See Materials and Methods for details of the
radiologic evaluation.
chronic reaction which was significantly more severe than
that induced by F-24 PG-PS on days 3 to 22 (P < 0.05).
Gross observations ofjoint injury induced by group A and
group D streptococcal PG-PS fragments were confirmed by
radiologic and histologic studies. The radiologic features of
group A streptococcal PG-PS-induced arthritis were similar
to those described in detail previously (9). Radiographs
taken on day 30 of ankle joints prior to the sacrifice of rats
for histologic study revealed no major differences. All joints
received a total radiologic score of 2 to 5 due to various
degrees of demineralization, periostitis, and soft tissue
swelling. No radiologic evidence of erosions was seen at 30
days (data not shown). Radiographs taken on day 110 of the
ankle joints of rats sacrificed for the day-128 histology study
revealed that the radiologic score for group A rats was
significantly higher than that for group D rats (Table 3).
Scores for rats receiving group D streptococci ATCC 9790
PG-PS were similar to those for rats receiving group D
streptococcal F-24 PG-PS, with clear evidence of
demineralization, periostitis, and soft tissue swelling. How-
ever, in constrast to ankles from group A streptococcal
PG-PS-injected rats, little or no evidence of erosions or
cartilage space narrowing was noted.
Histologic studies ofjoint tissue from rats sacrificed 3 days
after i.p. injection of group A or either strain of group D
streptococcal PG-PS revealed similar extensive acute exu-
dative reactions consisting of vascular congestion, evidence
of edema, fibrin deposits, infiltration by neutrophils and
mononuclear cells, and extravasation of erythrocytes. The
changes were most extensive in the stroma and synovial
membrane but also extended into the joint capsule and
periarticular tissues (Fig. 6a and b). Tissues collected 30, 60,
and 128 days after injection of group A streptococcal PG-PS
showed that the inflammatory process evolved into an ero-
sive destructive arthritis as previously described (13). The
types of changes observed are illustrated in Fig. 6c and e.
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Evidence of cartilage and bone erosion and chronic inflam-
mation was present in joints collected as late as 128 days
after injection. Tissues collected 30 and 60 days after injec-
tion of group D streptococcal F-24 PG-PS showed erosive
arthritis similar to that induced by group A streptococcal
PG-PS; however, the extent of the erosion of cartilage and
adjacent bone was less than that induced by group A
streptococcal PG-PS (Fig. 6d). The sections from rats sacri-
ficed 30 and 60 days after injection of group D streptococcal
ATCC 9790 PG-PS showed a moderately severe chronic
synovitis without evidence of erosion of cartilage and adja-
cent bone. The joints collected 128 days after injection of
PG-PS from either group D streptococcal strain showed
histologic evidence of previous injury, consisting of new
bone formation and fibrosis of the synovial stroma and
periarticular tissues, without evidence of active chronic
inflammation (Fig. 6f).
DISCUSSION
These studies show that a sterile, aqueous suspension of
PG-PS polymers from normal human flora can induce a wide
range of arthropathic responses upon i.p. injection into rats.
The pathology varies from a minimal acute arthritis (P.
acnes), to a moderately severe acute reaction and mild
chronic disease (Peptostreptococcus productus), to a severe
acute and chronic erosive arthritis (group D streptococci).
While group D streptococcal PG-PS clearly induced chronic
arthritis, it is of relatively short duration, leaving the joints
slightly enlarged, with histologic evidence of residual tissue
damage but without active, progressive chronic inflamma-
tion. The group B streptococcal cell wall fragments studied
by Spitznagel et al. (43) also induced chronic arthritis of
limited duration. Group A streptococcal PG-PS is the only
type we have worked with to date which has induced chronic
erosive arthritis of a recurrent irreversible nature leading to
joint destruction. L. casei cell wall fragments induced
chronic erosive arthritis of at least 60 days duration, but
whether this arthritis has the extraordinary long-term, recur-
rent, irreversible features of group A streptococcal PG-PS-
induced arthritis cannot be determined from the relatively
short-term experiments reported by Lehman et al. (29).
Previous reports have indicated that sonically treated
group D streptococcal whole cells induced little or no
arthritis, and group D streptococcal cell walls induced only a
transient acute joint inflammation (12, 13, 43). The determi-
nation ofwhat new aspect of purification (i.e., inactivation of
autolytic activity or preparation of the appropriate fragment
size) was most important in rendering group D streptococcal
PG-PS able to induce chronic erosive arthritis in the present
study will require more work. In any case, the new prepa-
ration probably more accurately reflects the intrinsic
arthropathic potential of group D streptococcal PG-PS.
Based on studies of the group A streptococcal PG-PS, the
major bacterial determinants of arthropathic activity include
the ability of the PG moiety to induce acute inflammation
(20) and the capacity of the PG-PS complex to persist in
tissue, which is correlated with resistance to hen egg white
lysozyme in vitro (17, 19, 32, 42). The nature of the joint
inflammation is also related to the molecular size of the
PG-PS complex (8, 20). The isolated PS moiety (7) and
low-molecular-weight PG-PS fragments (8) induce a tran-
sient edematous reponse in joint tissue upon systemic injec-
tion; this change in vascular permeability may be an impor-
tant event in the localization of PG-PS fragments to the
joints. In addition, since the removal of PS renders PG
sensitive to lysozyme, the PS contributes to the lysozyme
resistance of the PG-PS complex (37).
The inactivity upon intravenous injection and relative
inactivity upon i.a. injection of pseudomurein-PS fragments
from M. formicicum is consistent with a crucial role for the
PG moiety of the PG-PS. During purification, pseudomurein-
PS fragments behaved in a manner very similar to that of
conventional PG-PS, suggesting that their physical proper-
ties, such as size, sensitivity to sonic disruption, and sedi-
mentation characteristics, are similar to those of PG-PS
fragments. Thus, this nonarthropathic analog of PG-PS will
be useful as a control in future experiments. It will also be of
interest to determine whether the isolated pseudomurein
moiety has any of the biological activities, such as comple-
ment activation and adjuvanticity, of conventional PG. All of
the PG-PS types induced an acute inflammation upon i.a.
injection. The relative order of the severity and duration of
joint inflammation induced by the various PG-PS types
mimicked that seen in response to an i.p. injection.
The in vitro action of hen egg white lysozyme on the
PG-PS types studied here did not in itself predict ability to
induce chronic arthritis. However, the in vitro reaction with
hen egg white lysozyme may not represent the nature and
extent of PG-PS degradation caused by rat lysozyme and
peptidases in the in vivo milieu. The relationship between
PG-PS degradation and arthropathic activity is being pur-
sued in our laboratory by studying the in vivo degradation of
radiolabeled PG-PS fragments in rats.
With the exception of the group-specific PS of group A
streptococcal PG-PS, the detailed structures and biological
activities of the PS components of the various PG-PS com-
plexes are not known. It is intriguing that all of the PG-PS
polymers which induce chronic arthritis have in common
rhamnose as a major PS residue. However, given the short
list of PG-PS types thus far examined and the lack of
information on precise structural details, it would be prema-
ture to assign a crucial role to any specific PS structure or
component. The biological activities of the various PS poly-
mers and their abilities to influence the persistence and other
properties of the PG moiety will be investigated in future
studies.
P. acnes whole cells and cell walls have been the subject
of many investigations due to interest in the antitumor and
immunomodulatory activities of this organism (also known
FIG. 6. Histologic appearance of ankle joints prepared from rats sacrificed at intervals after the i.p. injection of group A or group D (F-24)
streptococcal PG-PS (magnification, x 120 for all photomicrographs). (a) Acute exudative reaction 3 days after group A streptococcal PG-PS
injection. A feature of the reaction is the presence of a large amount of fibrin in the joint space. (b) Acute exudative reaction, similar to that
induced by group A streptococcal PG-PS, 3 days after group D streptococcal PG-PS injection. (c) Chronic erosive synovitis 30 days after
group A streptococcal PG-PS injection. The destroyed cartilage and adjacent bone has been replaced by pannus consisting of capillaries and
hyperplastic fibrous tissue, infiltrated by mononuclear cells. (d) Chronic erosive arthritis, similar to that seen in response to group A
streptococcal PG-PS, 30 days after group D streptococcal PG-PS injection. (e) Arthritis 128 days after group A streptococcal PG-PS injection,
showing destruction of the cartilage and subchondral bone and replacement by fibrous tissue infiltrated with mononuclear cells. (f) Residual
joint damage 128 days after group D streptococcal PG-PS injection, showing fibrosis of the synovial tissue and ectopic formation of new bone.
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as Corynebacterium parvum, reviewed in reference 31).
Whole cells persist for long periods in vivo (38) and in
macrophages in vitro (33), which correlates with the in vitro
resistance of the PG-PS to lysozyme digestion. P. acnes cell
walls share other properties with group A streptococcal
PG-PS, including adjuvanticity (3, 24), mitogenicity (4), and
activation of the alternate complement pathway (45). In
contrast to group A streptococcal PG, Webster et al. (45)
found that P. acnes PG was not responsible for the comple-
ment-activating activity of cell walls. Also, a systemic injec-
tion of P. acnes PG was unable to induce a recurrence of
inflammation in joints given an i.a. injection of group A
streptococcal PG-PS 3 weeks earlier, whereas group A
streptococcal PG and group D streptococcal PG-PS were
both highly active in this model of recurrent inflammation
(R. E. Esser et al., Arth. Rheum., in press). These observa-
tions, considered with the relatively mild inflammation in-
duced by P. acnes PG-PS upon i.a. injection, suggest that
the capacity of P. acnes PG to induce acute inflammation
might reflect the reportedly unique structure of the peptide
region of P. acnes PG (24, 25) and might be responsible for
the weak arthropathic activity of P. acnes PG-PS upon i.p.
injection in rats. The arthropathic activity of P. acnes PG-PS
in this model is of particular interest since a high-molecular-
weight antigen which cross-reacts with a P. acnes PS antigen
has been reported to be extracted from synovial fluid and
synovial leukocytes from patients with rheumatoid arthritis
(5). Future experiments will examine the inflammatory and
other properties of the isolated PG structures of the various
PG-PS polymers.
We hypothesize that the normal flora, particularly of the
intestine, harbors a sufficiently diverse population of bacte-
ria to provide PG-PS polymers of many different sizes and
structures, capable of inducing a wide range of arthopathic
responses in the host. The varied responses induced by the
small representative group of polymers thus far studied
support this hypothesis. We further hypothesize that
arthropathic polymers might accumulate within the host
over a long period as a natural consequence of repeated
exposure to and uptake of certain albeit small amounts of
normal flora bacteria or bacterial debris from infection or
both. This process might be greatly accelerated when the
intestinal epithelium is damaged, as in gastrointestinal dis-
ease. Arthritis might then result, in the susceptible host,
from the accumulation of a certain threshold concentration
of arthropathic polymers in joint tissue. Wensinck and van
de Merwe (47) noted increased incidence of serum antibod-
ies against intestinal anaerobes, including the strain of Pep-
tostreptococcus productus used in our experiments, in
Crohn's disease patients, suggesting increased exposure to
indigenous intestinal bacteria. These studies, together with
the known association of arthritis with Crohn's and other
gastrointestinal diseases (2), are consistent with a role for
arthropathic PG-PS polymers derived from intestinal bacte-
ria in the etiology and pathogenesis of arthritis.
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